Transcriptomics

Dataset Information

3

Expression of V3 Versican by Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes


ABSTRACT: Arterial smooth muscle cells (ASMCs) undergo phenotypic changes during development and pathological processes in vivo and during cell culture in vitro. Our previous studies demonstrated that retrovirally-mediated expression of the versican V3 splice variant (V3) that lacks glycosaminoglycan chains by ASMCs retards cell proliferation and migration in vitro and reduces neointimal thickening, macrophage and lipid accumulation in animal models of vascular injury and atherosclerosis. However, the molecular pathways induced by V3 expression that are responsible for these changes are not yet clear. In the present study, we employed a microarray approach to examine how expression of V3 induced changes in gene expression and the molecular pathways in ASMCs. We found that forced expression of V3 by ASMCs affected expression of 521 genes by more than 1.5 fold. Gene ontology (GO) analysis shows that components of extracellular matrix were the most significantly affected by V3 expression, indicating that V3 expression elicits profound remodeling of extracellular matrix. In addition, genes regulating the formation of the cytoskeleton which also serve as markers of contractile smooth muscle cells were significantly upregulated. On the other hand, components of the complement system, chemokines, chemokine receptors, and transcription factors crucial for regulating inflammatory processes were among the genes most downregulated. Consistently, we found that the level of myocardin, a key transcription factor promoting contractile ASMC phenotype, was greatly increased while proinflammatory transcription factors NFkappaB1 and C/EBPβ were significantly attenuated in V3-expressing SMCs. Such results indicate that V3 expression reprograms ASMC into differentiated and anti-inflammatory phenotypes. Overall, these findings demonstrate that expression of V3 reprograms ASMCs promoting anti-inflammatory and differentiated smooth muscle cell phenotypes potentially by altering cell-ECM interaction and focal adhesion signaling pathways. Fischer rat ASMCs were transduced with either a retroviral vector expressing the Versican V3 splice variant (LV3SN) or an empty control vector (LXSN) in three independent experiments. In the first experiment, V3 and control transductions were performed with four technical replicates. In the subsequent two experiments, individual transductions were done for the V3 or control treatments. For data analysis, the technical replicates from the first experiment were averaged, and then data from the three experiments was evaluated in a paired manner.

ORGANISM(S): Rattus Norvegicus

SUBMITTER: Jeremy Barth   Jeremy L Barth  Thomas N Wight 

PROVIDER: E-GEOD-66624 | ArrayExpress | 2015-07-07

SECONDARY ACCESSION(S): GSE66624PRJNA277471

REPOSITORIES: GEO, ArrayExpress

Dataset's files

Source:
Action DRS
E-GEOD-66624.idf.txt Idf
E-GEOD-66624.processed.1.zip Processed
E-GEOD-66624.raw.1.zip Raw
E-GEOD-66624.sdrf.txt Txt
Items per page:
1 - 4 of 4

Similar Datasets

| E-GEOD-66624 | BioStudies
| S-EPMC4571886 | BioStudies
2011-01-01 | S-EPMC3123728 | BioStudies
| S-EPMC1602235 | BioStudies
| S-EPMC2906317 | BioStudies
| S-EPMC4503433 | BioStudies
| S-EPMC3822954 | BioStudies
| S-EPMC6161854 | BioStudies
| S-EPMC3314474 | BioStudies
| S-EPMC5999331 | BioStudies